|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02607 SH PHARMA
Nominal 
11.670 +0.120 (+1.039%) Non-current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Investment Properties | -- | -- | 366,010 | 314,673 | 246,415 | 213,323 |
| Property, plant, equip. & others | -- | -- | 17,059,697 | 15,724,684 | 14,316,653 | 13,398,248 |
| Land & other Lease Assets | -- | -- | 5,848,442 | 6,185,293 | 5,967,993 | 5,705,830 |
| Intangible Assets | -- | -- | 12,896,338 | 13,407,187 | 13,480,734 | 13,575,007 |
| Interests in Asso. & JCEs | -- | -- | 8,066,845 | 8,351,910 | 9,232,644 | 9,073,275 |
| Other Non-current Assets | -- | -- | 5,148,991 | 5,554,925 | 5,377,593 | 4,975,393 |
| -- | -- | 49,386,323 | 49,538,671 | 48,622,031 | 46,941,077 | |
Current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Inventories | -- | -- | 38,943,670 | 36,623,394 | 34,460,217 | 27,104,035 | |
| Trade Receivables | -- | -- | 80,251,311 | 74,842,530 | 68,559,438 | 59,386,651 | |
| Cash & Bank Balances | -- | -- | 35,744,328 | 30,517,706 | 27,401,396 | 22,390,386 | |
| Other Current Assets | -- | -- | 16,883,799 | 20,450,232 | 19,091,820 | 7,613,360 | |
| Assets Held for Sale | -- | -- | 0 | 0 | 0 | 0 | |
| -- | -- | 171,823,107 | 162,433,862 | 149,512,871 | 116,494,432 | ||
Current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |||
| Trade Payables | -- | -- | 59,482,920 | 54,632,454 | 51,565,529 | 41,995,414 | ||
| S-T Debt & Leases | -- | -- | 44,936,853 | 44,574,707 | 37,040,364 | 32,170,096 | ||
| Other Current Liabilities | -- | -- | 21,618,613 | 23,164,718 | 22,085,153 | 17,658,813 | ||
| Liab asso w/ Assets Held for Sale | -- | -- | 0 | 0 | 0 | 0 | ||
| -- | -- | 126,038,386 | 122,371,879 | 110,691,046 | 91,824,324 | |||
| Net Current Assets | -- | -- | 45,784,721 | 40,061,983 | 38,821,825 | 24,670,109 | ||
| Total Assets Less Current Liabilities | -- | -- | 95,171,044 | 89,600,655 | 87,443,855 | 71,611,186 | ||
Non-current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||||
| L-T Debt & Leases | -- | -- | 9,727,634 | 7,336,231 | 7,561,410 | 8,592,026 | |||
| Other Non-current Liabilities | -- | -- | 1,701,047 | 1,938,330 | 1,879,994 | 3,952,950 | |||
| -- | -- | 11,428,680 | 9,274,562 | 9,441,404 | 12,544,975 | ||||
Capital and Reserves
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |||||
| Share Capital | -- | -- | 3,707,972 | 3,703,301 | 3,697,546 | 2,842,089 | ||||
| Reserves | -- | -- | 67,967,648 | 64,820,842 | 63,365,460 | 46,517,391 | ||||
| Others | -- | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | -- | -- | 71,675,620 | 68,524,143 | 67,063,006 | 49,359,480 | ||||
| Non-controlling Interests | -- | -- | 12,066,744 | 11,801,950 | 10,939,445 | 9,706,730 | ||||
| Others | -- | -- | 0 | 0 | 0 | 0 | ||||
| -- | -- | 83,742,364 | 80,326,093 | 78,002,451 | 59,066,210 | |||||
Commitments and Contingent Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Commitments | -- | -- | 2,402,200 | 1,466,817 | 1,502,491 | 355,216 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 01/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 5,724,558 |
| %Change | 25.745% |
| EPS / (LPS) | RMB 1.540 |
| NBV Per Share (¥) | RMB -- |